Showing results (1941-1950 of 2,285) with videos related to

Sort By:
Pageof 229
Anesthesiology|February 28, 2022
Prophylactic Penehyclidine Inhalation for Prevention of Postoperative Pulmonary Complications in High-risk Patients: A Double-blind Randomized TrialTing Yan, Xin-Quan Liang, Guo-Jun Wang, et al.
Bioorganic Chemistry|June 2, 2020
Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screeningJie Han, Yucheng Tian, Liang Yu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 4, 2014
Genetic predictors of thiazide-induced serum potassium changes in nondiabetic hypertensive patientsChin-Chou Huang, Chia-Min Chung, Shuen-Iu Hung, et al.
Oncotarget|April 14, 2017
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancerFeng Yan, Le Ying, Xiaofang Li, et al.
Computers in Biology and Medicine|March 27, 2025
Distinguishing severe sleep apnea from habitual snoring using a neck-wearable piezoelectric sensor and deep learning: A pilot studyYi-Ping Chao, Hai-Hua Chuang, Zong-Han Lee, et al.
Frontiers in Medicine|July 8, 2022
SLC12A3 Variation and Renal Function in Chinese Patients With HypertensionChin-Chou Huang, Chia-Min Chung, Chih-Yu Yang, et al.
Medicine|June 17, 2022
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)Jia-Jun Wu, Po-Hsin Lee, Zhe-Rong Zheng, et al.
Frontiers in Cellular and Infection Microbiology|April 2, 2021
Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020Yajie Yuan, Liang Yu, Zi Jin, et al.
Theranostics|November 23, 2019
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarizationJinjin Peng, Jiacheng Li, Jing Huang, et al.
Annals of Hepatology|February 12, 2015
LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADVHongyu Jia, Feng Ding, Jianyang Chen, et al.
Pageof 229